Skip to main content
. Author manuscript; available in PMC: 2018 Mar 6.
Published in final edited form as: J Allergy Clin Immunol. 2015 Aug 5;137(1):289–298. doi: 10.1016/j.jaci.2015.06.030

FIG 4.

FIG 4

Combined effect of CysLT1R antagonist and EP3 antagonist on synergistic responses to LTD4 and PGE2. LAD2 cells (A–C) and hMCs (D and E) were preincubated with MK571 (1 μmol/L) and L-798 (100 nmol/L) separately or in combination and treated with LTD4 (0.5 μmol/L) ± PGE2 (0.5 μmol/L), and c-fos (Fig 4, A, B, D, and E) and MIP-1β (Fig 4, C) were analyzed. *P < .05, **P < .01, and ***P < .001.